RHEM : Presentation

Montpellier Experimental Histology Network (RHEM), created in 2008, is a platform specialized in histological processing, histological phenotyping, and anatomo-pathological analysis of tissues from experimental animal models of human diseases.

RHEM contributes to preclinical research in order to:

  • Better understand the pathophysiological mechanisms of diseases,
  • Assess the safety and efficacy of new therapies,
  • Identify new pathogenic or therapeutic targets.

By pooling human resources, equipment, and expertise, RHEM constitutes a unique resource for histological and anatomo-pathological analysis for the research stakeholders of Montpellier and the surrounding region.

Services and Integration within the Scientific Ecosystem

The platform also provides a scientific expertise upstream of experiments, support in result interpretation, methodological advice, as well as training in histology and immunohistology. It develops innovative technologies for the characterization of experimental models and constitutes a BioBank of healthy and pathological experimental tissues.

RHEM is part of a dynamic network and acts as a link between several strategic platforms:

  • the Montpellier Animal Facilities Network (RAM),
  • Montpellier Small Animal Imaging (IPAM),
  • and Montpellier Ressources Imaging (MRI).

All of them are federated within BioCampus Montpellier.

Our missions

Analyse

Ensure the histological processing, phenotyping, and anatomo-pathological analysis of tissues, in order to contribute to the understanding of diseases and the evaluation of innovative therapeutic approaches.

Accompany

Provide scientific expertise upstream and downstream of projects, advise research teams, train in histology and immunohistology techniques, and make high-performance equipment available.

Innovate

Develop new technological approaches to better characterize experimental models and enrich the BioBank of experimental tissues, thus promoting translational research and the valorization of discoveries.

Institutional Support and Funding

Our network is strongly supported by our supervisory institutions (CNRS, INSERM, and the University of Montpellier) as well as the Grand South-West Cancer Cluster, SiRIC MONTPELLIER Cancer, IBiSA (Infrastructure in Biology, Health, and Agronomy), the French League Against Cancer, the Occitanie-Méditerranée region, and Europe.